FDA Inspection
Taro Pharmaceuticals U.S.A., Inc.Taro Pharmaceuticals U.S.A., Inc. – FDA Inspection, Apr 18, 2013
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals U.S.A., Inc., with an inspection on April 18, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 18, 2013
- Product Type
- Drugs
View Company Profile
ID · ab1f6be7-8d0f-438f-b95a-5deb99505433
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 827465
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
FDA Citations
3- 21 CFR 314.80(c)Failure by applicant to report ADE
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taro Pharmaceuticals U.S.A., Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Taro Pharmaceuticals U.S.A., Inc.
- FDA Inspection 1066575 - 2018-08-27
- FDA Inspection 907479 - 2014-12-19
- FDA Inspection 769594 - 2012-03-08
- FDA Inspection 592198 - 2009-05-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.